These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36822370)

  • 21. Endemic and Epidemic Human Alphavirus Infections in Eastern Panama: An Analysis of Population-Based Cross-Sectional Surveys.
    Carrera JP; Cucunubá ZM; Neira K; Lambert B; Pittí Y; Liscano J; Garzón JL; Beltran D; Collado-Mariscal L; Saenz L; Sosa N; Rodriguez-Guzman LD; González P; Lescano AG; Pereyra-Elías R; Valderrama A; Weaver SC; Vittor AY; Armién B; Pascale JM; Donnelly CA
    Am J Trop Med Hyg; 2020 Dec; 103(6):2429-2437. PubMed ID: 33124532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Quantitative Real-Time RT-PCR Assay for the Detection of
    Vina-Rodriguez A; Eiden M; Keller M; Hinrichs W; Groschup MH
    Biomed Res Int; 2016; 2016():8543204. PubMed ID: 28042576
    [No Abstract]   [Full Text] [Related]  

  • 24. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
    Atasheva S; Kim DY; Frolova EI; Frolov I
    J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PERK Is Critical for Alphavirus Nonstructural Protein Translation.
    Dahal B; Lehman CW; Akhrymuk I; Bracci NR; Panny L; Barrera MD; Bhalla N; Jacobs JL; Dinman JD; Kehn-Hall K
    Viruses; 2021 May; 13(5):. PubMed ID: 34065980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.
    Nguyen TH; Haese NN; Madadi N; Sarkar S; Bonin K; Streblow CE; Taft-Benz S; Tower NA; Rasmussen L; Bostwick R; Augelli-Szafran CE; Suto MJ; Morrison TE; DeFilippis V; Heise MT; Streblow DN; Pathak AK
    ACS Infect Dis; 2019 Dec; 5(12):2014-2028. PubMed ID: 31257853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.
    Haese NN; May NA; Taft-Benz S; Moukha-Chafiq O; Madadi N; Zhang S; Karyakarte SD; Rodzinak KJ; Nguyen TH; Denton M; Streblow AD; Towers NA; Rasmussen L; Bostwick RJ; Maddry JA; Ananthan S; Augelli-Szafran CE; Suto MJ; Sanders W; Moorman N; DeFilippis V; Heise MT; Pathak AK; Streblow DN; Morrison TE
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0024421. PubMed ID: 34152810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.
    Ahmed A; Bakovic A; Risner K; Kortchak S; Der Torossian Torres M; de la Fuente-Nunez C; Lu T; Bhalla N; Narayanan A
    Sci Rep; 2020 Dec; 10(1):21491. PubMed ID: 33293592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses.
    Boghdeh NA; McGraw B; Barrera MD; Anderson C; Baha H; Risner KH; Ogungbe IV; Alem F; Narayanan A
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus.
    Zhang R; Hryc CF; Cong Y; Liu X; Jakana J; Gorchakov R; Baker ML; Weaver SC; Chiu W
    EMBO J; 2011 Aug; 30(18):3854-63. PubMed ID: 21829169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
    Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
    Fierro C; Weidenthaler H; Vidojkovic S; Schmidt D; Gafoor Z; Stroukova D; Zwiers S; Müller J; Volkmann A
    Vaccine; 2024 Apr; 42(10):2695-2706. PubMed ID: 38494412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA structures within Venezuelan equine encephalitis virus E1 alter macrophage replication fitness and contribute to viral emergence.
    Hickson SE; Hyde JL
    PLoS Pathog; 2024 Sep; 20(9):e1012179. PubMed ID: 39331659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection.
    Painter GR; Bowen RA; Bluemling GR; DeBergh J; Edpuganti V; Gruddanti PR; Guthrie DB; Hager M; Kuiper DL; Lockwood MA; Mitchell DG; Natchus MG; Sticher ZM; Kolykhalov AA
    Antiviral Res; 2019 Nov; 171():104597. PubMed ID: 31494195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of IKKβ in Venezuelan equine encephalitis virus infection.
    Amaya M; Voss K; Sampey G; Senina S; de la Fuente C; Mueller C; Calvert V; Kehn-Hall K; Carpenter C; Kashanchi F; Bailey C; Mogelsvang S; Petricoin E; Narayanan A
    PLoS One; 2014; 9(2):e86745. PubMed ID: 24586253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.
    Hollidge BS; Cohen CA; Akuoku Frimpong J; Badger CV; Dye JM; Schmaljohn CS
    Virulence; 2021 Dec; 12(1):430-443. PubMed ID: 33487119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venezuelan equine encephalitis virus: the problem is not over for tropical America.
    Guzmán-Terán C; Calderón-Rangel A; Rodriguez-Morales A; Mattar S
    Ann Clin Microbiol Antimicrob; 2020 May; 19(1):19. PubMed ID: 32429942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.